Zydus receives final approval from the USFDA for Minocycline Hydrochloride Extended-Release Tablets

Zydus receives final approval from the USFDA for Minocycline Hydrochloride Extended-Release Tablets

The product will be manufactured at the group’s formulation manufacturing facility in Moraiya, Ahmedabad (India).

FPJ Web DeskUpdated: Monday, June 19, 2023, 03:43 PM IST
article-image
Zydus receives final approval from the USFDA for Minocycline Hydrochloride Extended-Release Tablets | Image: Zydus (Representative)

Zydus Lifesciences Limited has received final approval from the United States Food and Drug Administration (USFDA) for Minocycline Hydrochloride Extended-Release Tablets USP, 55 mg, 65 mg, and 115 mg.

Minocycline Hydrochloride Extended-Release is used to treat moderate to severe acne in people 12 years and older. Minocycline belongs to a class of drugs known as tetracycline antibiotics. The product will be manufactured at the group’s formulation manufacturing facility in Moraiya, Ahmedabad (India).

Minocycline Hydrochloride Extended-Release Tablets USP, 55 mg, 65 mg, and 115 mg had annual sales of USD 0.7 mn in the United States.

The group now has 372 approvals and has so far filed over 442* ANDAs since the commencement of the filing process in FY 2003-04.

RECENT STORIES

Closing Bell: Markets End Day In Red; Sensex At 69,521.69, Nifty Below 20,950

Closing Bell: Markets End Day In Red; Sensex At 69,521.69, Nifty Below 20,950

Pencil-maker DOMS Industries' Rs 1,200 cr IPO to open on Dec 13

Pencil-maker DOMS Industries' Rs 1,200 cr IPO to open on Dec 13

Paytm Shares Drop 18% After Shift To Larger Loans, Slowing Loans Below ₹50,000

Paytm Shares Drop 18% After Shift To Larger Loans, Slowing Loans Below ₹50,000

Tata Motors Partners With HDFC Bank For Commercial Vehicle Financing

Tata Motors Partners With HDFC Bank For Commercial Vehicle Financing

Levying Border Adjustment Tax To Meet Green Commitments Morally Wrong, Says Finance Minister Nirmala...

Levying Border Adjustment Tax To Meet Green Commitments Morally Wrong, Says Finance Minister Nirmala...